Stay updated on Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page
- CheckyesterdayChange DetectedRheumatoid arthritis is removed from the Related Topics section, and the related topics header along with the MedlinePlus Genetics link are deleted. This changes the page's navigational context by removing disease-specific resources.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page now includes added related topics (Rheumatoid arthritis and MedlinePlus Genetics) and a newer revision tag (v3.6.3) replacing the previous v3.6.0.SummaryDifference0.1%

- Check15 days agoChange DetectedRheumatoid arthritis and the related topics section, including MedlinePlus Genetics, were removed from the page, reducing the visibility of the study’s disease context and related educational resources.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page now indicates that recruitment for this study is closed, and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a formatting adjustment to the Intervention/Treatment header and a version update from v3.5.5 to v3.6.0.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5. This is a metadata change that does not modify the study content or visible information.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page shows a new Revision label (v3.5.4) replacing the previous version, indicating a backend/UI maintenance update rather than an addition or deletion of study content.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.